Effect of Wii Fit Training in Comparison to Vestibular Rehabilitation Training on Balance in Patients With Benign Paroxysmal Postional Vertigo

December 13, 2024 updated by: Foundation University Islamabad
THIS STUDY IS A RANDOMIZED CONTROL TRIAL AND THE PURPOSE OF THE STUDY IS TO DETERMINE THE EFFECT OF WIIFIT TRAINING IN COMPARISON TO VESTIBULAR REHAB TRAINING ON BALANCE IN PATIENTS WITH BENIGN PAROXYSMAL POSITIONAL VERTIGO

Study Overview

Status

Recruiting

Conditions

Intervention / Treatment

Detailed Description

Effects of wiifit training will be assessed for balance and vertigo which includes the parameters of balance training.

Benign Paroxysmal Positional Vertigo patients aged 30-60 years The participants will be assessed through Vestibular Rehabilitation questionnaire (VRBQ), Dizziness handicap inventory (DHI), Functional reach test, Clinical test for sensory integration in balance and vertigo symptom scale.

Informed consent will be taken after which the participants will be recruited into two groups, where one group will receive wiifit training and other group will receive vestibular rehabilitation training.

Base-line and post-treatment measurement will be taken for analysis.

Study Type

Interventional

Enrollment (Estimated)

38

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

  • Pakistan
      • Islamabad, Pakistan, 44000
        • Recruiting
        • Foundation University College of Physical Therapy
        • Contact:

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • Patients diagnosed with benign paroxysmal positional vertigo.
  • Aged 30-60 years.
  • Ability to stand and walk independently.
  • Male and Female
  • Positive Dix Hallpike Test
  • DHI Scale: 36-42 (moderate Handicap)

Exclusion Criteria:

  • patients with history of vestibular surgery or cochlear implantation.
  • Patients with history of seizures or epilepsy.
  • patients with a pacemaker or implantable cardioverter-defibrillator(ICD).
  • Patients with history of severe head injury or concussion within the past year.
  • No other vestibular disorders or conditions that may affect balance.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Experimental group A

The participants will receive intervention through Wii fit training which includes games tight rope tension, ski slalom, penguin slide, table tilt, and heading for 6 total 6 weeks.

3 days per week session will be given for 30 minutes including 5-minutes warmup and cool down and 5 minutes of break in between to avoid fatigue.
Procedure: INTERVENTION GROUP : TRAINING WITH WIIFIT
RCT (RANDOMIZED CONTROL TRIAL) GROUP 1 : Wii FIT TRAINING TIGHT ROPE TENSION, SKI SLALOM, PENGUIN SLIDE, TABLE TILT GROUP 2 : VESTIBULAR REHABILITATION TRAINING WEIGHT SHIFTING, NECK ROTATIONS, SIT TO STAND EXERCISES ON PADDED MAT AND HEAD MOVEMENTS WITH EYES CLOSED.
Active Comparator: Experimental group B

The participants will receive vestibular rehabilitation training. The rehabilitation programme will include weight shifting, neck rotations, sit to stand exercises on padded mat, and head movements with eyes closed.

The intervention will be given for 3 minutes, 3 days a week for total 6 weeks of time period.
Procedure: VESTIBULAR REHABILITATION TRAINING
WEIGHT SHIFTING, NECK ROTATIONS, SIT TO STAND EXERCISES ON PADDED MAT AND HEAD MOVEMENTS WITH EYES CLOSED.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Static Balance
Time Frame: 6 weeks
The Vestibular Rehabilitation Benefit Questionnaire (VRBQ) is a validated tool used to measure balance 0 means no problem, 100 means severe problem
6 weeks
Vertigo
Time Frame: 6 weeks
DHI scale is used to assess vertigo.The questionnaire consists of 25 items with 3 responses YES= 4 points SOMETIMES = 2 points and NO = 0 points. The total score ranges from 0 to 100, higher score indicating self perceived handicap due to dizziness.
6 weeks
Static Balance
Time Frame: 6 weeks
CTSIB of Biodex is used to assess static balance and has 4 components. a) Firm surface with eyes open; (Mean value 0.44)test the integration of visual,somatosensory and vestibular inputs. All sensory systems are available for balance. b) Firm surface with eyes closed; (mean value 0.80)evaluate the reliance on somatosensory input for balance and visual input is eliminated.c) Foam surface with eyes open; (Mean value; 0.79) Test the ability to use visual and vestibular inputs for balance when somatosensory inputs is unreliable,unstable surface. d) Foam surface with eyes closed; (mean value 2.41) primarily challenges the vestibular system by eliminating visual input and providing unreliable somatosensory feedback. The total mean of these 4 components is 1.11.
6 weeks
Dynamic balance
Time Frame: 6 weeks

Functional Reach test will be used to assess dynamic balance

  • Scoring:
  • Distance in centimeters or inches is recorded.
  • Normal values :
  • <15 cm indicates a high fall risk in older adults
6 weeks

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Foundation University Islamabad

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

July 20, 2024

Primary Completion (Actual)

December 1, 2024

Study Completion (Estimated)

December 20, 2024

Study Registration Dates

First Submitted

November 28, 2024

First Submitted That Met QC Criteria

December 13, 2024

First Posted (Actual)

March 25, 2025

Study Record Updates

Last Update Posted (Actual)

March 25, 2025

Last Update Submitted That Met QC Criteria

December 13, 2024

Last Verified

November 1, 2024

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • FUI/CTR/2024/52

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Vertigo

Clinical Trials on INTERVENTION GROUP : TRAINING WITH WIIFIT

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Kazakhstan

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

Subscribe